Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
RHOC
REST API REST API
Homo sapiens
RHOC is differentially expressed in 285 experiments: 125 organism parts: bone marrow, heart, ... (123 more);, 214 disease states: normal, glioblastoma, ... (212 more);, 117 cell types 402 cell lines 34 compound treatments and 71 other conditions.
Synonyms RhoC, ARH9, ARHC
Orthologs rhoae (Danio rerio)   F1NNU0_CHICK (Gallus gallus)   Rhoc (Rattus norvegicus)   RHO1 (Saccharomyces cerevisiae)   rhoad (Danio rerio)   RHOC_BOVIN (Bos taurus)   Rhoc (Mus musculus)   Q7YT82_CIOIN (Ciona intestinalis)   Rho1 (Drosophila melanogaster)   rhoc (Xenopus laevis)   RHOC (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, plasma membrane, positive regulation of caspase activity, GTPase activity, protein binding, cleavage furrow, positive regulation of translation, axon, cytoplasm, intracellular, membrane, regulation of dendrite development, protein domain specific binding, response to hypoxia, membrane fraction, signal transducer activity, GTP catabolic process, soluble fraction, positive regulation of actin filament polymerization, GTP binding, axon guidance, small GTPase mediated signal transduction, nucleus, regulation of small GTPase mediated signal transduction, nucleotide binding, response to drug, positive regulation of cell growth, neuron projection morphogenesis, regulation of actin polymerization or depolymerization, response to ethanol, stress-activated protein kinase signaling cascade, signal transduction, response to mechanical stimulus, protein transport, positive regulation of I-kappaB kinase/NF-kappaB cascade, positive regulation of cell adhesion, negative regulation of calcium ion transport via voltage-gated calcium channel activity, negative regulation of I-kappaB kinase/NF-kappaB cascade, positive regulation of cell migration, negative regulation of neuron differentiation, response to amino acid stimulus, cell cycle cytokinesis, positive regulation of neuron apoptosis, response to glucose stimulus, response to glucocorticoid stimulus, positive regulation of vasoconstriction
InterPro Term MIRO-like, ProtSyn_GTP-bd, Small_GTPase, Small_GTP-bd_dom, Small_GTPase_ARF/SAR, Small_GTPase_Ras, Small_GTPase_Rho, Small_GTPase_Rab_type
UniProt Accession P08134, Q5JR08, Q5JR05, Q5JR07, Q5JR06, E9PN11, E9PQH6, E9PLA2
Search EB-eye ENSG00000155366
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-22541, E-GEOD-6573, E-MEXP-433, E-GEOD-3526, ... (25 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (43 experiments)

Factor Value U/D Experiments
HL-60
1
3
E-GEOD-5258, E-MTAB-37, E-GEOD-24147, E-GEOD-96
BT474
2
E-MTAB-37, E-MEXP-440
T84
2
E-MTAB-37, E-GEOD-1474
BT20
2
E-MTAB-37, E-MTAB-62
MCF7
2
E-GEOD-5258, E-MTAB-37
MOLT4
2
E-MTAB-62, E-MTAB-37
396 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, ... (57 experiments)

Factor Value U/D Experiments
endothelial cell
1
3
E-GEOD-19240, E-GEOD-96, E-GEOD-3920, E-GEOD-3998
CD56+ NK cells
2
E-AFMX-5, E-TABM-145
bronchial epithelial
2
E-AFMX-5, E-MTAB-25
stromal cell
2
E-GEOD-1460, E-GEOD-3998
white blood cell
1
E-GEOD-2006
CD16 negative
1
E-GEOD-16836
111 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-MEXP-1121, E-TABM-15, E-GEOD-16363, ... (54 experiments)

Factor Value U/D Experiments
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
astrocytoma
2
E-GEOD-4290, E-MTAB-62
chronic lymphocytic leukemia
2
E-GEOD-2466, E-GEOD-6691
chronic myelogenous leukemia
2
E-MTAB-62, E-GEOD-96
colon carcinoma
2
E-MTAB-62, E-MTAB-37
control
2
E-GEOD-21912, E-GEOD-20602
208 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-15205, E-TABM-782, E-GEOD-3720, E-GEOD-5824, ... (22 experiments)

Factor Value U/D Experiments
none
2
3
E-TABM-782, E-GEOD-5824, E-GEOD-412, E-GEOD-5418, E-GEOD-20719 ... (5 experiments)
unknown
1
E-GEOD-7307
2-(3,4,5-trimethoxy-phenylamino)-pyrrolo[2,3-d]pyrimidines
1
E-GEOD-6932
hydroxyurea
1
E-GEOD-6431
phorbol 12-myristate 13-acetate + ionomycin
1
E-GEOD-3720
heregulin
1
E-GEOD-6462
28 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-2171, ... (9 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-1140, E-MEXP-1251, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-GEOD-4667, E-MTAB-62 ... (5 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-MEXP-480, E-TABM-147, E-GEOD-3013

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7011, E-MEXP-1482, E-MTAB-108, E-MEXP-2340

Genotype
studied in E-GEOD-1923, E-GEOD-22056, E-GEOD-2466, E-GEOD-17476, E-GEOD-22593, ... (10 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-7011, E-TABM-127, E-GEOD-20540, E-GEOD-22278, E-GEOD-837, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-GEOD-2466, E-MEXP-2069, ... (36 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-MEXP-561

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977, E-TABM-321

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Library source
studied in E-GEOD-19323

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-26495, E-GEOD-1309, E-GEOD-21750, E-GEOD-1657, E-GEOD-7114 ... (5 experiments)

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19445, ... (6 experiments)

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-1509, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-MEXP-70, E-GEOD-17400

Sex
studied in E-GEOD-19743, E-GEOD-2466

Stimulation
studied in E-GEOD-20114, E-GEOD-23984, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Tissue
studied in E-GEOD-30573

Treatment
studied in E-GEOD-21909, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561

Vehicle
studied in E-GEOD-5258

Processing time: 0.264 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM